Print

Biosimilars Committee

Global Biosimilars Week: Message of the IGBA Chair

IGBA member companies are the pioneers and global leaders in the development and marketing of biosimilar medicines. The objectives of the IGBA Biosimilars Committee shall be to represent, support and develop, where appropriate and necessary, the common scientific and technical interests of the biosimilar medicines industry, members of IGBA. One of the key objectives is promoting and supporting globally the scientific concept of biosimilarity.

Contact Info

IGBA | INTERNATIONAL GENERIC AND BIOSIMILAR MEDICINES ASSOCIATION

C/O DYN SA
Rue de Cornavin 11
1201 Geneva, Switzerland

Telephone: +32 (0)2 5346607 (S. Kox)
E-mails: 
This email address is being protected from spambots. You need JavaScript enabled to view it.  
or  
Secretary General –   This email address is being protected from spambots. You need JavaScript enabled to view it.

We use cookies to improve our website and your experience when using it. Cookies used for the essential operation of the site have already been set. To find out more about the cookies we use and how to delete them, see our Privacy Policy.

I accept cookies from this site